Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
$2.48B |
| 2 |
Wells Fargo
WFC
|
$2.4B |
| 3 |
NVIDIA
NVDA
|
$2.03B |
| 4 |
American Express
AXP
|
$948M |
| 5 |
Amazon
AMZN
|
$855M |
Top Sells
| 1 |
Pfizer
PFE
|
$1.71B |
| 2 |
Chubb
CB
|
$1.57B |
| 3 |
ConocoPhillips
COP
|
$1.49B |
| 4 |
Microsoft
MSFT
|
$1.37B |
| 5 |
Advanced Micro Devices
AMD
|
$1.15B |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Healthcare | 20.37% |
| 3 | Financials | 14.37% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Verrica Pharmaceuticals
VRCA
$48.2M
| $606K | ﹤0.01% |
+10,239
| New | +$606K |
|
1677
Marathon Digital Holdings
MARA
$5.63B
| $605K | ﹤0.01% |
26,783
-992
| -4% | -$22.4K |
|
1678
Organogenesis Holdings
ORGO
$634M
| $585K | ﹤0.01% |
+205,846
| New | +$585K |
|
1679
Tourmaline Bio
TRML
$687M
| $571K | ﹤0.01% |
+24,945
| New | +$571K |
|
1680
Regenxbio
RGNX
$490M
| $566K | ﹤0.01% |
26,849
-11,686
| -30% | -$246K |
|
1681
BioMarin Pharmaceuticals
BMRN
$11.1B
| $552K | ﹤0.01% |
6,320
+254
| +4% | +$22.2K |
|
|
IGMS
1682
DELISTED
IGM Biosciences
IGMS
| $552K | ﹤0.01% |
+57,190
| New | +$552K |
|
1683
Invesco QQQ Trust
QQQ
$368B
| $544K | ﹤0.01% |
1,226
-18,988
| -94% | -$8.43M |
|
1684
Capricor Therapeutics
CAPR
$308M
| $542K | ﹤0.01% |
+79,759
| New | +$542K |
|
1685
iShares MSCI Brazil ETF
EWZ
$5.47B
| $532K | ﹤0.01% |
16,406
+8,990
| +121% | +$291K |
|
1686
Palantir
PLTR
$363B
| $524K | ﹤0.01% |
22,771
+9,202
| +68% | +$212K |
|
1687
Nutanix
NTNX
$18.7B
| $523K | ﹤0.01% |
8,467
+1,681
| +25% | +$104K |
|
1688
APA Corp
APA
$8.14B
| $518K | ﹤0.01% |
+15,080
| New | +$518K |
|
1689
MindMed
MNMD
$702M
| $518K | ﹤0.01% |
+55,065
| New | +$518K |
|
1690
TAL Education Group
TAL
$6.17B
| $512K | ﹤0.01% |
45,150
-3,514
| -7% | -$39.9K |
|
1691
Dow Inc
DOW
$17.4B
| $512K | ﹤0.01% |
8,835
| – | – |
|
|
TBNK
1692
DELISTED
Territorial Bancorp Inc.
TBNK
| $500K | ﹤0.01% |
62,002
-489
| -0.8% | -$3.94K |
|
|
CTLT
1693
DELISTED
CATALENT, INC.
CTLT
| $496K | ﹤0.01% |
8,778
-684
| -7% | -$38.6K |
|
1694
Stanley Black & Decker
SWK
$12.1B
| $485K | ﹤0.01% |
4,952
+894
| +22% | +$87.5K |
|
1695
Upbound Group
UPBD
$1.47B
| $482K | ﹤0.01% |
13,681
| – | – |
|
1696
Vail Resorts
MTN
$5.87B
| $478K | ﹤0.01% |
2,145
+80
| +4% | +$17.8K |
|
|
NBIS
1697
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $477K | ﹤0.01% |
50,402
| – | – |
|
1698
Carrier Global
CARR
$55.8B
| $475K | ﹤0.01% |
8,167
-26,293
| -76% | -$1.53M |
|
1699
Franklin Resources
BEN
$13B
| $464K | ﹤0.01% |
16,521
+1,415
| +9% | +$39.8K |
|
1700
Arcutis Biotherapeutics
ARQT
$2.06B
| $461K | ﹤0.01% |
+46,547
| New | +$461K |
|